E. Ruth Plummer

A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules

Alan V. Boddy, E. Ruth Plummer, R Todd et al. · Clinical Cancer Research · 2005 · 108 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines

Michelle J. Clarke, Evan A. Mulligan, Patrick T. Grogan et al. · Molecular Cancer Therapeutics · 2009 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer

Ahmed Elattar, Katharine G. Warburton, Asima Mukhopadhyay et al. · Gynecologic Oncology · 2011 · 62 citations

Medicine, Endocrinology, Oncology +16

A phase Ib study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI

Branimir I. Šikić, Heather A. Wakelee, Margaret von Mehren et al. · Journal of Clinical Oncology · 2007 · 49 citations

Life Sciences, Oncology, Pharmacology +17

High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers

Barry Dent, Laura Ogle, R O’Donnell et al. · International Journal of Cancer · 2015 · 48 citations · Full text

Medicine, Cell Biology, Oncology +17